Author
Listed:
- Tyler E. Miller
(Lerner Research Institute, Cleveland Clinic
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Case Western Reserve University School of Medicine
Case Western Reserve University School of Medicine)
- Brian B. Liau
(Harvard Medical School
Epigenomics Program, Broad Institute
Massachusetts General Hospital)
- Lisa C. Wallace
(Lerner Research Institute, Cleveland Clinic)
- Andrew R. Morton
(Lerner Research Institute, Cleveland Clinic
Case Western Reserve University School of Medicine)
- Qi Xie
(Lerner Research Institute, Cleveland Clinic)
- Deobrat Dixit
(Lerner Research Institute, Cleveland Clinic)
- Daniel C. Factor
(Case Western Reserve University School of Medicine)
- Leo J. Y. Kim
(Lerner Research Institute, Cleveland Clinic
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Case Western Reserve University School of Medicine)
- James J. Morrow
(Case Western Reserve University School of Medicine
Case Western Reserve University School of Medicine)
- Qiulian Wu
(Lerner Research Institute, Cleveland Clinic)
- Stephen C. Mack
(Lerner Research Institute, Cleveland Clinic
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University)
- Christopher G. Hubert
(Lerner Research Institute, Cleveland Clinic
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University)
- Shawn M. Gillespie
(Harvard Medical School
Epigenomics Program, Broad Institute
Massachusetts General Hospital)
- William A. Flavahan
(Lerner Research Institute, Cleveland Clinic
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University)
- Thomas Hoffmann
(Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))
- Rohit Thummalapalli
(Harvard Medical School
Epigenomics Program, Broad Institute
Massachusetts General Hospital)
- Michael T. Hemann
(The Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology)
- Patrick J. Paddison
(Fred Hutchinson Cancer Research Center)
- Craig M. Horbinski
(Feinberg School of Medicine, Northwestern University
Feinberg School of Medicine, Northwestern University)
- Johannes Zuber
(Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))
- Peter C. Scacheri
(Case Western Reserve University School of Medicine)
- Bradley E. Bernstein
(Harvard Medical School
Epigenomics Program, Broad Institute
Massachusetts General Hospital)
- Paul J. Tesar
(Case Western Reserve University School of Medicine)
- Jeremy N. Rich
(Lerner Research Institute, Cleveland Clinic
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
University of California at San Diego)
Abstract
An in vivo RNA interference screening strategy in glioblastoma enabled the identification of a host of epigenetic targets required for glioblastoma cell survival that were not identified by parallel standard screening in cell culture, including the transcription pause–release factor JMJD6, and could be a powerful tool to uncover new therapeutic targets in cancer.
Suggested Citation
Tyler E. Miller & Brian B. Liau & Lisa C. Wallace & Andrew R. Morton & Qi Xie & Deobrat Dixit & Daniel C. Factor & Leo J. Y. Kim & James J. Morrow & Qiulian Wu & Stephen C. Mack & Christopher G. Huber, 2017.
"Transcription elongation factors represent in vivo cancer dependencies in glioblastoma,"
Nature, Nature, vol. 547(7663), pages 355-359, July.
Handle:
RePEc:nat:nature:v:547:y:2017:i:7663:d:10.1038_nature23000
DOI: 10.1038/nature23000
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Faye M. Walker & Lays Martin Sobral & Etienne Danis & Bridget Sanford & Sahiti Donthula & Ilango Balakrishnan & Dong Wang & Angela Pierce & Sana D. Karam & Soudabeh Kargar & Natalie J. Serkova & Nicho, 2024.
"Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy,"
Nature Communications, Nature, vol. 15(1), pages 1-21, December.
- Jieqiong Zhang & Zhenhua Hu & Hwa Hwa Chung & Yun Tian & Kah Weng Lau & Zheng Ser & Yan Ting Lim & Radoslaw M. Sobota & Hwei Fen Leong & Benjamin Jieming Chen & Clarisse Jingyi Yeo & Shawn Ying Xuan T, 2023.
"Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis,"
Nature Communications, Nature, vol. 14(1), pages 1-21, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:547:y:2017:i:7663:d:10.1038_nature23000. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.